The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

被引：0
|
作者：
Vladimer Darsalia
Martin Larsson
Thomas Klein
Cesare Patrone
机构：
[1] Karolinska Institutet,Department of Clinical Science and Education, Södersjukhuset, Internal Medicine
[2] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Glucagon-like peptide 1 receptor; Dipeptidyl peptidase-4 inhibitors; Stroke; Diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
    Darsalia, Vladimer
    Larsson, Martin
    Klein, Thomas
    Patrone, Cesare
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [2] The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
    Secrest, Matthew H.
    Udell, Jacob A.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (03) : 194 - 202
  • [3] Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Payk, Stephanie L.
    Drew, Richard H.
    Smith, Jennifer D.
    Jiroutek, Michael R.
    Holland, Melissa A.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1477 - 1482
  • [4] GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician?
    Scheen, Andre J.
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 515 - 522
  • [5] DPP-4 inhibitors and GLP-1 receptor agonists. Cardiovascular effects
    Nauck, M. A.
    El Aziz, M. S. Abd
    Meier, J. J.
    DIABETOLOGE, 2016, 12 (03): : 184 - +
  • [6] Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review
    Bihan, Helene
    Ng, Winda L.
    Magliano, Dianna J.
    Shaw, Jonathan E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 121 : 27 - 34
  • [7] Global View on Safety and Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors
    Timofte, L.
    Stratmann, B.
    Bojita, M. T.
    Quester, W.
    Tschoepe, D.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (01): : 19 - 27
  • [8] Impact of Either GLP-1 Agonists or DPP-4 Inhibitors on Pathophysiology of Heart Failure
    Takahashi, Ayako
    Ihara, Madoka
    Yamazaki, Satoru
    Asanuma, Hiroshi
    Asakura, MaSarlori
    Kitakaze, Masafumi
    INTERNATIONAL HEART JOURNAL, 2015, 56 (04) : 372 - 376
  • [9] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [10] Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
    Brown, Dominique Xavier
    Evans, Marc
    JOURNAL OF NUTRITION AND METABOLISM, 2012, 2012
12345